Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California
- PMID: 32329797
- PMCID: PMC7182961
- DOI: 10.1001/jama.2020.7202
Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California
Abstract
This case series characterizes the demographics, health services use, and vital status and discharge dispositions of patients with polymerase chain reaction–confirmed coronavirus disease 2019 (COVID-19) hospitalized in the Kaiser Permanente Northern California health system in March 2020.
Conflict of interest statement
Figures
Similar articles
-
Simulation of the effects of COVID-19 testing rates on hospitalizations.Bull World Health Organ. 2020 May 1;98(5):299. doi: 10.2471/BLT.20.258186. Bull World Health Organ. 2020. PMID: 32514192 Free PMC article. No abstract available.
-
Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States.J Gen Intern Med. 2020 Aug;35(8):2516-2517. doi: 10.1007/s11606-020-05937-5. Epub 2020 Jun 9. J Gen Intern Med. 2020. PMID: 32519326 Free PMC article. No abstract available.
-
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.Emerg Infect Dis. 2020 Aug;26(8):1679-1685. doi: 10.3201/eid2608.201776. Epub 2020 May 14. Emerg Infect Dis. 2020. PMID: 32407284 Free PMC article.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
COVID-19: Main therapeutic options.Tunis Med. 2020 Apr;98(4):299-303. Tunis Med. 2020. PMID: 32395792 Review. No abstract available.
Cited by
-
Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential.Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197-9. Online ahead of print. Oncogene. 2024. PMID: 39487323
-
Efficacy and safety of a novel antiviral herbal preparation in ICU-admitted patients with COVID-19: A phase III double-blinded controlled trial.Avicenna J Phytomed. 2024 Mar-Apr;14(2):215-228. doi: 10.22038/AJP.2023.23259. Avicenna J Phytomed. 2024. PMID: 38966633 Free PMC article.
-
Comparative analysis of prognostic scoring systems in predicting severity and outcomes of Omicron variant COVID-19 pneumonia.Front Med (Lausanne). 2024 Jun 18;11:1419690. doi: 10.3389/fmed.2024.1419690. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38957300 Free PMC article.
-
Descriptive epidemiology of COVID-19 in Japan 2020: insights from a multihospital database.Ann Clin Epidemiol. 2022 Sep 29;5(1):5-12. doi: 10.37737/ace.23002. eCollection 2023. Ann Clin Epidemiol. 2022. PMID: 38505379 Free PMC article.
-
Mental health and risk of death and hospitalization in COVID-19 patients. Results from a large-scale population-based study in Spain.PLoS One. 2024 Feb 12;19(2):e0298195. doi: 10.1371/journal.pone.0298195. eCollection 2024. PLoS One. 2024. PMID: 38346044 Free PMC article.
References
-
- Centers for Disease Control and Prevention Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12-March 16, 2020. Morbidity and Mortality Weekly Report Updated March 27, 2020. Accessed March 27, 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm - PMC - PubMed
